This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024

Adamas Nanotechnologies, Inc.

Profile

Adámas Nanotechnologies produces fluorescent diamond particles (FDP) for imaging and quantum sensing in biomedical research with high clinical translational potential. Exceptional photostability and biocompatibility of FDP renders their use as fluorescent labels in longitudinal biomedical studies, while uniquely coupled fluorescence and electron spin properties enables use as ultrasensitive, cellular environmental sensors analytes such as metabolites, free radicals, and temperature. Adámas’ core expertise is the production of FDP with properties optimized for imaging and quantum sensing. This is exemplified by development of end-use solutions for clinical and biomanufacturing analysis of biochemical species. A broad range of FDP products provided by Adámas are supported by a large number of patents (>25) related to nanodiamond properties, processing, and applications. Over the past three years, Adamas has been awarded numerous governmental support (NIH and DOE) for extensive R&D resulting in rapid growing of our FDP portfolio adapted to specific biomedical and biomanufacturing needs.